Umair Shariff, MD, MHA


Handling IV Solutions Presents Challenges

Pharmacies should ensure appropriate monitoring procedures are in place to prevent contamination and exposure.

Mike Hennessy Jr, President and CEO


Diversity, Equity, and Inclusion Are Crucial in Pharmacy

Pharmacy Times® commits to incorporating DEI concepts into our coverage and focusing on social determinants of health (SDOH).

Jenny Peña, CPhT


Technicians Play Key Roles in Health Systems

Seventeen percent work in hospital settings, including compounding, inpatient, medication reconciliation, and outpatient areas.

Britny Rogala, PharmD, BCOP


Overview of PARP Inhibitors in the Treatment of Ovarian Cancer

There are 3 PARP inhibitors that are FDA approved in multiple settings of ovarian cancer.

Winston Su


Pharmacists Can Help Treat Post-Intensive Care Syndrome

Managing transitions of care is vital to discontinue use of unnecessary drugs and minimize medication errors.

Elise Palatine


Approval of Tapinarof Introduces New Class of Topical Treatments for Management of Plaque Psoriasis

Tapinarof is a first-in-class topical steroid-free aryl hydrocarbon receptor antagonist intended to mitigate the symptoms of plaque psoriasis.

Judy Neville, CPhT


AAPT to Celebratbrate National Pharmacy Technician Day With Scavenger Hunt

With National Pharmacy Technician Day 2021 on October 19, AAPT Special Projects Team offers a Scavenger Hunt to celebrate this special day and the pharmacy technicians who work hard to add value to their profession.

Tara Pfund, PharmD


NCPA President Discusses 3 Ways to Ride the Pharmacy Surge Wave

Implement technology solutions, initiate clinical services, and shift to a proactive mindset, Michele Belcher says.

Tanapong Pantasri, PharmD, RPh, BCMTMS


How Pharmacists Can Protect Patients from Outdated COVID-19 Treatment

The pharmacist is the last barrier between a patient and a drug, which is why it's critical for pharmacists to check for allergies, potential drug interactions, patient understanding of how to use the drug, and whether the prescription is appropriate for the diagnosis.

Timothy E Samuelson, RPh


Evaluation of a Chemotherapy Advanced Preparation Pilot Program to Improve Throughput in an Oncology Infusion Clinic

Pharmacy workflow changes in the preparation of chemotherapy products can reduce patient chair time.

Gary E. Ritchie


Current Good Manufacturing Practices Are Reliable Safeguard

Properly implemented CGMP should not be seen as a regulatory burden but a remedy to poorly compounded drugs.

Dong Won Kim, PharmD candidate


TXNIP inhibitors: A New Class of Agents for Diabetes Treatment

TXNIP inhibition could prevent beta cell loss and protect beta cell function to potentially contribute to diabetes management and its complications.

Shereen Stutz, RPh


Medically Integrated Pharmacies, Oral Oncolytic Agents Grow in Importance During COVID-19

As practices have gained experience in the post-COVID-19 environment, health care professionals have found innovative ways to work around many of the obstacles the pandemic presents.

Jisu Eo


Advancing Multistate Licensure Is Vital in Telehealth Era

But meeting regulatory requirements may entail a great deal of financial expertise and time.

Jacques Turgeon, BPharm, PhD


Pharmacists Play Role in Pharmacogenomics Clinical Services

They should consider many factors and use clear guidance on predicting phenotypes from genotypes to intervene optimally based on specific drug-gene interactions.

Stefanie C. Nigro, PharmD, BCACP, CDCES


Case Studies- January 2023

Case studies address questions about a patient with type 2 diabetes and a patient who is curious about nicotine replacement therapy.

Prasanna Parthasarathy, CEO, Medvantx


Non-commercial Pharmacies: The Missing Link in Breaking Down Barriers to Medication Access

Patient-centric models of medication delivery that provide cost, transparency, convenience, and accessibility solutions are vital for patients to successfully navigate the current health care system.

Akiva Faerber


Op-Ed: Unnecessary Transfusions in Hospitals May Be Fueling the Blood Shortage

With costs for blood and blood products continuing to rise, appropriate blood use by hospitals is more important than ever.

Emilia Welch, PharmD


Oncology Overview: Atezolizumab (Tecentriq)

Since its initial approval in 2016 for urothelial carcinoma, atezolizumab has received FDA approval for an additional 5 types of carcinomas.

Shaina Shah, PharmD Candidate


Biosimilar Adoption: Patient and Provider Considerations

From a patient perspective, the lack of awareness of biosimilars is the biggest barrier to adoption.

Audrey B Kostrzewa, PharmD, MPH, BCPS


Fire on the Mountain: Addressing Pharmacy Staff Burnout

The entire pharmacy profession and all those interested in medication safety need to coalesce around the need for systemic change in community pharmacy workplace environments.

Linda Clark


Gridlock, Middleman Lobbying Cause Pharmacy Benefit Manager Reforms to Fail Again in New York Budget

Many pharmacies and safety-net providers were preparing for the long-anticipated transition from Medicaid managed care to fee-for-service (FFS)—known as the carve-out—that was set to take effect on May 1, 2021.

Sarena Lott


Fungal Biomarkers: Primer for Pharmacists

Biomarkers are commonly used by physicians to assist in the earlier diagnosis of some of the most common fungal diseases.

Dan Cua, PhD


New Binding Mechanism Science Driving Therapeutic Insight in Immune-Mediated Diseases

The ability of an anti-interleukin-23 antibody to bind to key immune system components may help neutralize a key driver of inflammation right at its cellular source.

Marcie Morris, PharmD, CSP


Emerging Therapies Are Changing the Melanoma Treatment Landscape

Specialty pharmacists play critical role in supporting treatment adherence.

Monazzah Akbar Sarwar, PharmD


New Therapeutic Agents and Final Thoughts on DED

A panel of experts comment on new therapeutic agents being developed and discuss their final thoughts on dry eye disease.

Sarah Zentack, InformedDNA


Dig Deeper Into Dementia: Clinical Trials Explore Genetic Component of FTD

Although frontotemporal dementia is the leading cause of the disease for those under 65 years of age, far fewer people are familiar with it than with Alzheimer disease.

Ryan Jacobs, MD


Future Directions for the Treatment of CLL

Bhavesh Shah, RPh, BCOP, and Ryan Jacobs, MD, discuss emerging agents in the pipeline and the future treatment landscape for CLL.

Asad Ghani


Deprescribing Helps Optimize Medication Use

Frequent reassessments of therapy regimens address polypharmacy, particularly for older patients.

Neo Su and Ben Shirley


PQA and CPF Lead National Initiative to Prioritize Pharmacy Measure Concepts

Concepts could be used in payer-pharmacy value-based arrangements.

© 2023 MJH Life Sciences

All rights reserved.